March 30, 2015 4:59 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top biotechnology stocks on the NASDAQ in terms of operating margin.The trailing-twelve-month operating margin at
PDL BioPharma, Inc. (NASDAQ: PDLI) is 94.00%. PDL BioPharma's PEG ratio is 0.28.The trailing-twelve-month operating margin at
Enzon Pharmaceuticals Inc. (NASDAQ: ENZN) is 92.30%. Enzon Pharmaceuticals' EPS for the same period is $0.65.The trailing-twelve-month operating margin at
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) is 76.20%. Enanta Pharmaceuticals' revenue for the same period is $124.30 million.The trailing-twelve-month operating margin at
NewLink Genetics Corporation (NASDAQ: NLNK) is 68.10%. NewLink Genetics' EPS growth forecast for the next year is 4.40%.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.